Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Progress toward the clinical application of patient-specific pluripotent stem cells.

Kiskinis E, Eggan K.

J Clin Invest. 2010 Jan;120(1):51-9. doi: 10.1172/JCI40553. Review.

2.

Therapeutic application of stem cell technology toward the treatment of Parkinson's disease.

Nishimura K, Takahashi J.

Biol Pharm Bull. 2013;36(2):171-5. Review.

3.

Disease-specific pluripotent stem cells.

Kang HC.

Korean J Pediatr. 2010 Aug;53(8):786-9. doi: 10.3345/kjp.2010.53.8.786. Epub 2010 Aug 31.

4.

Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease.

Chen LW, Kuang F, Wei LC, Ding YX, Yung KK, Chan YS.

CNS Neurol Disord Drug Targets. 2011 Jun;10(4):449-58. Review.

PMID:
21495962
5.

Current progress and prospects of induced pluripotent stem cells.

Chen L, Liu L.

Sci China C Life Sci. 2009 Jul;52(7):622-36. doi: 10.1007/s11427-009-0092-6. Epub 2009 Jul 30. Review.

PMID:
19641867
6.

Somatic cell reprogramming for regenerative medicine: SCNT vs. iPS cells.

Pan G, Wang T, Yao H, Pei D.

Bioessays. 2012 Jun;34(6):472-6. doi: 10.1002/bies.201100174. Epub 2012 Mar 15. Review.

PMID:
22419173
7.

Induced pluripotent stem cell research: a revolutionary approach to face the challenges in drug screening.

Song M, Paul S, Lim H, Dayem AA, Cho SG.

Arch Pharm Res. 2012 Feb;35(2):245-60. doi: 10.1007/s12272-012-0205-9. Epub 2012 Feb 28. Review.

PMID:
22370779
8.

Epigenetic reprogramming of the germ cell nuclear factor gene is required for proper differentiation of induced pluripotent cells.

Wang H, Wang X, Xu X, Zwaka TP, Cooney AJ.

Stem Cells. 2013 Dec;31(12):2659-66. doi: 10.1002/stem.1367.

9.

Reprogrammed cells for disease modeling and regenerative medicine.

Cherry AB, Daley GQ.

Annu Rev Med. 2013;64:277-90. doi: 10.1146/annurev-med-050311-163324. Review.

10.

Are induced pluripotent stem cells the future of cell-based regenerative therapies for spinal cord injury?

Salewski RP, Eftekharpour E, Fehlings MG.

J Cell Physiol. 2010 Mar;222(3):515-21. doi: 10.1002/jcp.21995. Review.

PMID:
20020443
11.

Reprogramming therapeutics: iPS cell prospects for neurodegenerative disease.

Abeliovich A, Doege CA.

Neuron. 2009 Feb 12;61(3):337-9. doi: 10.1016/j.neuron.2009.01.024.

12.

[Pluripotent stem cells for cell replacement therapy of diabetes].

Naujok O, Lenzen S.

Dtsch Med Wochenschr. 2012 May;137(20):1062-6. doi: 10.1055/s-0032-1304936. Epub 2012 May 8. Review. German.

PMID:
22570100
13.

Prospects of induced pluripotent stem cell technology in regenerative medicine.

Zhang F, Citra F, Wang DA.

Tissue Eng Part B Rev. 2011 Apr;17(2):115-24. doi: 10.1089/ten.TEB.2010.0549. Epub 2011 Feb 15. Review.

PMID:
21210760
14.

Advances in culture and manipulation of human pluripotent stem cells.

Qian X, Villa-Diaz LG, Krebsbach PH.

J Dent Res. 2013 Nov;92(11):956-62. doi: 10.1177/0022034513501286. Epub 2013 Aug 9.

15.

Evolution of induced pluripotent stem cell technology.

Zhou H, Ding S.

Curr Opin Hematol. 2010 Jul;17(4):276-80. doi: 10.1097/MOH.0b013e328339f2ee. Review.

PMID:
20442654
16.

Mouse induced pluripotent stem cells.

Geoghegan E, Byrnes L.

Int J Dev Biol. 2008;52(8):1015-22. doi: 10.1387/ijdb.082640eg. Review.

17.

Lectin microarray analysis of pluripotent and multipotent stem cells.

Toyoda M, Yamazaki-Inoue M, Itakura Y, Kuno A, Ogawa T, Yamada M, Akutsu H, Takahashi Y, Kanzaki S, Narimatsu H, Hirabayashi J, Umezawa A.

Genes Cells. 2011 Jan;16(1):1-11. doi: 10.1111/j.1365-2443.2010.01459.x. Epub 2010 Dec 13.

18.

[Breakthrough in research on pluripotent stem cells and their application in medicine].

Valdimarsdóttir G, Richter A.

Laeknabladid. 2015 Dec;101(12):581-6. doi: 10.17992/lbl.2015.12.56. Review. Icelandic.

PMID:
26656400
19.

Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors.

Kim JB, Zaehres H, Wu G, Gentile L, Ko K, Sebastiano V, Araúzo-Bravo MJ, Ruau D, Han DW, Zenke M, Schöler HR.

Nature. 2008 Jul 31;454(7204):646-50. doi: 10.1038/nature07061. Epub 2008 Jun 29.

PMID:
18594515
20.

Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons.

Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H, Chung W, Croft GF, Saphier G, Leibel R, Goland R, Wichterle H, Henderson CE, Eggan K.

Science. 2008 Aug 29;321(5893):1218-21. doi: 10.1126/science.1158799. Epub 2008 Jul 31.

Supplemental Content

Support Center